Research is key to future treatment
The BRC is a partnership between The Royal Marsden and The Institute of Cancer Research, London. It supports innovative translational research, taking leading-edge cancer research from the laboratory and rapidly translating it into a clinical setting.
Public engagement events: register now
Our “What does the future hold for cancer?” programme of events engages with the public and patients to showcase our research and its impact on cancer care and treatment.
Coming up: Hairy cell leukaemia (28 September), Breast cancer (1 October), Gynaecological cancers & Sarcoma (8 October)
Latest news
News: AI reveals breast cancer types that respond differently to treatment
Scientists have used artificial intelligence to recognise patterns in breast cancer – and uncovered five new types of the disease each matched to different personalised treatments
Find out more
News: Personalised ‘liquid biopsy’ could detect return of breast cancer
A new study at five UK hospitals has found that a personalised blood test for women with early breast cancer could detect the return of the disease nearly eleven months earlier than hospital scans.
Find out more
News: Immunotherapy option for bowel cancer
A major new study reveals that bowel cancer patients who have become resistant to a widely used targeted treatment could benefit from immunotherapy.
Find out more